Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Magnesium toxicity from OTC drugs "underestimated," FDAers say in journal article.

This article was originally published in The Tan Sheet

Executive Summary

MAGNESIUM TOXICITY FROM OTC DRUGS "UNDERESTIMATED" by consumers and health care professionals, according to an article by three FDAers in the August issue of the American Medical Association's Archives of Family Medicine. The study, based on adverse event reports collected in FDA's MEDWATCH database, a case report and a literature review, was authored by former OTC Medical Officer Man Fung, MD, Office of OTC Drug Evaluation Director Michael Weintraub, MD, and Medical Review Staff Director Debra Bowen, MD.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts